Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Otol Neurotol ; 45(9): 971-984, 2024 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-39264916

RESUMEN

OBJECTIVE: To assess hearing and speech outcomes in pediatric patients with bilateral cochlear nerve deficiency (CND) who underwent cochlear implantation (CI) and to identify factors associated with improved outcomes. DATABASES REVIEWED: PubMed, Embase, Web of Science, and Cochran databases were searched following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. METHODS: Studies that reported hearing and speech outcomes of pediatric patients with bilateral CND who underwent CI were included. Demographics, comorbidities, inner ear abnormalities, CND classification (aplasia or hypoplasia), details of diagnostic workup, and outcomes data were extracted. Outcomes were assessed using the four-level auditory performance level (APL) scale. Meta-analysis, using Cochran-Armitage tests, was performed on patients with individual data to assess factors associated with performance. RESULTS: A total of 314 papers were screened, and 40 papers with 378 total patients met inclusion criteria. A total of 339 patients had patient-level data and were included in the meta-analysis. Of the 339 patients, 19% (n = 63) of patients had no measurable stimulation, 28% (n = 95) had improved detection, 22% (n = 76) achieved closed-set speech perception, and 31% (n = 105) achieved open-set speech perception. Patients with cochlear nerve aplasia (p = 0.016) and syndromes (p < 0.001) had significantly worse APL scores relative to patients with cochlear nerve hypoplasia and patients without syndromes, respectively. CONCLUSIONS: While most patients with bilateral CND benefit from CI and almost one-third of patients achieved open-set speech perception, outcomes were heterogenous and one-fifth of patients did not experience measurable benefit from CI.


Asunto(s)
Implantación Coclear , Nervio Coclear , Humanos , Implantación Coclear/métodos , Niño , Nervio Coclear/anomalías , Nervio Coclear/cirugía , Resultado del Tratamiento , Percepción del Habla/fisiología , Enfermedades del Nervio Vestibulococlear/cirugía , Preescolar
2.
Int J Pediatr Otorhinolaryngol ; 184: 112076, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39178603

RESUMEN

BACKGROUND: Patients with long-COVID suffer from symptoms that continue or develop after a COVID-19 or SARS-CoV-2 infection and are present for four or more weeks after the initial infection. This case series describes a group of previously healthy adolescent patients with long-COVID who were seen in a pediatric vestibular clinic for evaluation of severe dizziness and were diagnosed with persistent postural-perceptual dizziness (PPPD). By presenting their symptoms, management and treatment effects, this study aims to provide a diagnostic and therapeutic framework for providers who encounter these patients. METHODS: Patient records were reviewed for past medical history, symptoms, physical exam findings, results of audiometric and vestibular testing, dizziness handicap inventory for patient caregiver (DHI-pc) scores, and treatment recommendations. Parents of patients were contacted for a follow up survey to assess treatment adherence and outcomes including changes in symptoms and return to activity. RESULTS: A series of 9 adolescent patients were referred from a multidisciplinary long-COVID clinic and diagnosed with PPPD. Recommended treatment included vestibular physical therapy, selective serotonin reuptake inhibitor medication, and cognitive behavioral therapy. The majority of patients experienced an improvement in their symptoms, and all patients had improved activity levels and DHI-pc scores after treatment. CONCLUSION: To the best of our knowledge, no previous reports exist discussing PPPD in long-COVID patients. This case series provides insight into symptom evolution and treatment efficacy in this patient population.


Asunto(s)
COVID-19 , Mareo , Humanos , COVID-19/complicaciones , Masculino , Femenino , Adolescente , Mareo/diagnóstico , Mareo/terapia , Mareo/etiología , Niño , Equilibrio Postural/fisiología , SARS-CoV-2 , Terapia Cognitivo-Conductual/métodos , Modalidades de Fisioterapia , Síndrome Post Agudo de COVID-19 , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico
3.
Eur J Neurosci ; 58(3): 2708-2723, 2023 08.
Artículo en Inglés | MEDLINE | ID: mdl-37461313

RESUMEN

Meniere's disease (MD) is a disorder of the inner ear characterized by chronic episodes of vertigo, tinnitus, increased aural pressure, and sensorineural hearing loss. Causes of MD are unknown, but endolymphatic hydrops is a hallmark. In addition, 5%-15% of MD cases have been identified as familial. Whole-genome sequencing studies of individuals with familial MD identified DTNA and FAM136A as candidate genes for autosomal dominant inheritance of MD. Although the exact roles of these genes in MD are unknown, FAM136A encodes a mitochondrial protein, and DTNA encodes a cytoskeletal protein involved in synapse formation and maintenance, important for maintaining the blood-brain barrier. It is also associated with a particular aquaporin. We tested vestibular and auditory function in dtna and fam136a knockout (KO) mice, using RotaRod and startle reflex-based clicker tests, respectively. Three-factor analysis of variance (ANOVA) results indicated that sex, age, and genotype were significantly correlated with reduced mean latencies to fall ("latencies") for male dtna KO mice, while only age was a significant factor for fam136a KO mice. Fam136a KO mice lost their hearing months before WTs (9-11 months vs. 15-20 months). In male dtna KO mice, divergence in mean latencies compared with other genotypes was first evident at 4 months of age, with older males having an even greater decrease. Our results indicate that fam136a gene mutations generate hearing problems, while dtna gene mutations produce balance deficits. Both mouse models should help to elucidate hearing loss and balance-related symptoms associated with MD.


Asunto(s)
Pérdida Auditiva Sensorineural , Enfermedad de Meniere , Vestíbulo del Laberinto , Animales , Ratones , Masculino , Enfermedad de Meniere/genética , Enfermedad de Meniere/complicaciones , Enfermedad de Meniere/diagnóstico , Reflejo de Sobresalto , Mutación
4.
Cureus ; 11(12): e6504, 2019 Dec 29.
Artículo en Inglés | MEDLINE | ID: mdl-32025425

RESUMEN

Background and objectives The presence of mutans streptococci has been used in individual assessments of caries risk. In the modern era of dentistry, the chair side kits for assessing chair side cariogenic bacteria play a significant role. There is paucity of literature about the comparison of commercially available chair side caries risk tests. Hence this study was conducted to compare the efficacy of three commercially available chair side cariogenic bacteria tests. Methodology Twenty-five patients in the age group of 5-14 years were selected. The saliva samples of patients were collected and were taken for cariogenic bacteria tests using caries risk test (CRT) bacteria test kit and saliva check mutans kit (mutans rapid detection kit). The plaque samples were taken for CariScreen caries susceptibility testing meter. All the samples were compared with a gold standard, i.e., mitis salivarius-bacitracin (MSB) agar plate test. Results Results demonstrated that the specificity of CariScreen and caries risk test was 91.67 whereas it was 75.00 for saliva check mutans. The CariScreen produced the risk status of the patient in shortest time. However, all the chair side kits failed to show the exact colony count of bacteria. Conclusion The result of the current study proved that both CariScreen and caries risk test are highly efficient in assessing the caries risk of patients. However, the CariScreen is easy to perform and provides the result in shorter time.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...